| 英文别名： |
Etonogestrel;Etonogestrel Solution;[3H]-3-keto-Desogestrel;3-keto-Desogestrel;3-Keto-desogestrel 3-Oxo-desogestrel;3-Ketodesogestrel,3-Oxodesogestrel,Org-3236,Implanon;3-oxodesogestrel;Desogestrel Related Compound C (25 mg) (3-Keto-desogestrel);Etonoestrel;Implanon;org3236;(17α)-13-Ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-one;3-Oxo-desogestrel;13-Ethyl-17-ethynyl-17-hydroxy-11-methylidene-2,6,7,8,9,10,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one;nexplanon;3-Ketodesogestrel;etonogestrelum;ORG 3236;304GTH6RNH;Implanon (TN);Etonogestrel (USAN/I;EN300-19767790;13-Ethyl-17-hydroxy-11-methylidene-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one (3-Ketodesogestrel);DESOGESTREL IMPURITY D (EP IMPURITY);13-Ethyl-17-hydroxy-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one;18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-11-methylene-, (17-alpha)-;SCHEMBL117703;GTPL7590;EINECS 258-936-2;CHEBI:50777;NCGC00168777-01;18,19-Dinorpregn-4-en-20-yn-3-one,13-ethyl-17-hydroxy-11-methylene-, (17a)-;Tox21_112638;BCP28481;UNII-304GTH6RNH;13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol-3-one;18,19-DINOR-17.ALPHA.-PREGN-4-EN-20-YN-3-ONE, 13-ETHYL-17-HYDROXY-11-METHYLENE-;Etonogestrel [USAN:INN:BAN];3-Oxodesogestrel;HY-B0652;Etonogestrel, >=98% (HPLC);13-Ethyl-11-methylene-18,19-dinor-17-alpha-pregn-4-en-20-yn-3-one;3-oxo desogestrel;NS00006394;17alpha-ethynyl-17beta-hydroxy-11-methylidene-18a-homo-estr-4-en-3-one;Etonogestrel (USAN/INN);(1R,3aS,3bS,9aR,9bS,11aS)-11a-ethyl-1-ethynyl-1-hydroxy-10-methylidene-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one;C75537;Etonogestrel, United States Pharmacopeia (USP) Reference Standard;AKOS030526156;Org-3236;DESOGESTREL IMPURITY D;NUVARING COMPONENT ETONOGESTREL;ETONOGESTREL COMPONENT OF NUVARING;(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one;DTXSID9046782;ETONOGESTREL;ETONOGESTREL (USP-RS);18,19-Dinor-17alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-11-methylene-;ETONOGESTREL [USAN];(17alpha)-13-Ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-one;NCGC00168777-04;CAS-54048-10-1;(1S,2R,10S,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxy-17-methylidenetetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one;ETONOGESTREL [MART.];17-Ethinyl-17-beta-hydroxy-18-methyl-11-methylene-4-estren-3-one;ETONOGESTREL [USP-RS];DESOGESTREL IMPURITY D [EP IMPURITY];ETONOGESTREL [INN];A829925;(17-alpha)-13-Ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-one;ETONOGESTREL [VANDF];AS-73246;D04104;ETONOGESTREL (MART.);ETONOGESTREL [MI];BDBM50423516;3-Keto-desogestrel;DB00294;(17-alpha)-13-ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-on;CHEMBL1531;ETONOGESTREL [WHO-DD];G03AC08;CCG-267753;s4673;ETONOGESTREL [ORANGE B... |
沪公网安备 
